VentriPoint Diagnostics Ltd Total Liabilities
VentriPoint Diagnostics Ltd total liabilities. Based on the latest financial reports, VentriPoint Diagnostics Ltd (VPT) has total liabilities worth CA$4.59 Million CAD (≈ $3.32 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See VPT defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Total Liabilities of VentriPoint Diagnostics Ltd (2005–2025)
Total liabilities of VentriPoint Diagnostics Ltd from 2005 to 2025. This chart illustrates how VentriPoint Diagnostics Ltd's total liabilities have evolved over time, based on quarterly financial data.
VentriPoint Diagnostics Ltd Competitors by Total Liabilities
The table below lists competitors of VentriPoint Diagnostics Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
TwentyFour Income Fund Ltd
LSE:TFIF
|
UK | GBX26.16 Million |
|
aXichem AB
ST:AXIC-A
|
Sweden | Skr9.69 Million |
|
Admiralty Resources NL
AU:ADY
|
Australia | AU$18.25 Million |
|
Four Leaf Acquisition Corporation Class A Common Stock
NASDAQ:FORL
|
USA | $26.89 Million |
|
i2S SA
PA:ALI2S
|
France | €6.67 Million |
|
Trailbreaker Resources Ltd
V:TBK
|
Canada | CA$268.94K |
|
G Capital Bhd
KLSE:7676
|
Malaysia | RM66.75 Million |
Liability Composition Analysis (2005–2025)
This chart breaks down VentriPoint Diagnostics Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see VentriPoint Diagnostics Ltd total assets.
Liquidity & Leverage Metrics
VentriPoint Diagnostics Ltd Total Liabilities Ratios Explained
VentriPoint Diagnostics Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.08 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.11 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 9.72 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how VentriPoint Diagnostics Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for VentriPoint Diagnostics Ltd (2005–2025)
The table below shows the annual total liabilities of VentriPoint Diagnostics Ltd from 2005 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CA$4.59 Million ≈ $3.32 Million |
+26.07% |
| 2024-12-31 | CA$3.64 Million ≈ $2.63 Million |
+114.91% |
| 2023-12-31 | CA$1.69 Million ≈ $1.23 Million |
+19.01% |
| 2022-12-31 | CA$1.42 Million ≈ $1.03 Million |
+17.54% |
| 2021-12-31 | CA$1.21 Million ≈ $875.90K |
-61.56% |
| 2020-12-31 | CA$3.15 Million ≈ $2.28 Million |
+13.17% |
| 2019-12-31 | CA$2.78 Million ≈ $2.01 Million |
+93.35% |
| 2018-12-31 | CA$1.44 Million ≈ $1.04 Million |
-56.84% |
| 2017-12-31 | CA$3.34 Million ≈ $2.41 Million |
+14.16% |
| 2016-12-31 | CA$2.92 Million ≈ $2.11 Million |
+19.31% |
| 2015-12-31 | CA$2.45 Million ≈ $1.77 Million |
-15.17% |
| 2014-12-31 | CA$2.89 Million ≈ $2.09 Million |
-25.62% |
| 2013-12-31 | CA$3.88 Million ≈ $2.81 Million |
+1.49% |
| 2012-12-31 | CA$3.83 Million ≈ $2.77 Million |
-19.83% |
| 2011-12-31 | CA$4.77 Million ≈ $3.45 Million |
+86.28% |
| 2010-12-31 | CA$2.56 Million ≈ $1.85 Million |
-26.05% |
| 2009-12-31 | CA$3.46 Million ≈ $2.51 Million |
+53.25% |
| 2008-12-31 | CA$2.26 Million ≈ $1.63 Million |
+278.51% |
| 2007-12-31 | CA$597.11K ≈ $431.94K |
+6161.83% |
| 2006-12-31 | CA$9.54K ≈ $6.90K |
+67.67% |
| 2005-12-31 | CA$5.69K ≈ $4.11K |
-- |
About VentriPoint Diagnostics Ltd
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), which transforms standard 2D and 3D echocardiography and a medical imaging system that is used to generate three-dimensional models with critical volume and functional m… Read more